[Spastic flexion disorders: clinical and metabolic problems observed during treatment with zinc tetracosactide].
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives*; D003366:Cosyntropin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced; D015032:Zinc / Q000009:adverse effects
D003366:Cosyntropin; D000324:Adrenocorticotropic Hormone; D015032:Zinc
Maladie des spasmes en flexion: troubles cliniques et métaboliques observés en cours de traitement par le tétracosactide zinc